scispace - formally typeset
A

A. Jager

Researcher at VU University Amsterdam

Publications -  17
Citations -  2666

A. Jager is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Type 2 diabetes & Population. The author has an hindex of 17, co-authored 17 publications receiving 2595 citations.

Papers
More filters
Journal ArticleDOI

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

TL;DR: To determine the incidence of diabetes in relation to baseline fasting and postload glucose levels and other risk factors, a population-based cohort study among 1342 nondiabetic white residents of Hoorn, the Netherlands among participants with IFG, IGT, and normal glucose levels at baseline was conducted.
Journal ArticleDOI

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study.

TL;DR: It is concluded that both microalbuminuria and peripheral arterial disease (PAD), a generally accepted marker of generalized atherosclerosis, are associated with an increased risk of cardiovascular mortality.
Journal ArticleDOI

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.

TL;DR: Increased levels of von Willebrand factor (vWf) and C-reactive protein (CRP) are independently associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects, favoring the hypothesis that vWf and CRP predict mortality through different pathways.
Journal ArticleDOI

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.

TL;DR: Levels of sVCAM-1 are independently associated with the risk of cardiovascular mortality in type 2 diabetic subjects and therefore might be useful for identifying subjects at increased cardiovascular risk, and argue against the hypotheses of s VCAM- 1 levels simply being a marker of endothelial dysfunction, of low-grade inflammation, or of an impaired renal function.
Journal ArticleDOI

Serum homocysteine level and protein intake are related to risk of microalbuminuria : The Hoorn Study

TL;DR: Both hyperhomocysteinemia and protein intake are related to microalbuminuria independent of NIDDM and hypertension, and may partly explain the link between MA and increased risk of cardiovascular disease.